Preprint Review Version 1 This version is not peer-reviewed

Arylpiperazine Derivatives and Cancer: A New Challenge in Medicinal Chemistry

Version 1 : Received: 18 July 2024 / Approved: 19 July 2024 / Online: 19 July 2024 (10:53:08 CEST)

How to cite: Andreozzi, G.; Corvino, A.; Severino, B.; Magli, E.; Perissutti, E.; Frecentese, F.; Santagada, V.; Caliendo, G.; Fiorino, F. Arylpiperazine Derivatives and Cancer: A New Challenge in Medicinal Chemistry. Preprints 2024, 2024071574. https://doi.org/10.20944/preprints202407.1574.v1 Andreozzi, G.; Corvino, A.; Severino, B.; Magli, E.; Perissutti, E.; Frecentese, F.; Santagada, V.; Caliendo, G.; Fiorino, F. Arylpiperazine Derivatives and Cancer: A New Challenge in Medicinal Chemistry. Preprints 2024, 2024071574. https://doi.org/10.20944/preprints202407.1574.v1

Abstract

In recent decades, there has been a startling rise in the number of cancer patients worldwide, which has led to an amazing upsurge in the development of novel anticancer treatment candidates. On a positive note, arylpiperazines have garnered attention in cancer research due to their potential as scaffolds for developing anticancer agents. These compounds exhibit a diverse array of biological activities, including cytotoxic effects against cancer cells. Indeed, one of the key advantages of aryl piperazines lies in their ability to interact with various molecular targets implicated in cancer pathogenesis. Here, we focus on the chemical structures of several arylpiperazine derivatives, highlighting their anti-proliferative activity in different tumor cell lines. The modular structure, diverse biological activities, and potential for combination therapies of arylpiperazine com-pounds make them valuable candidates for further preclinical and clinical investigations in the fight against cancer. This review, providing a careful analysis of different arylpiperazine deriva-tives and their biological applications, allows researchers to refine the chemical structures to improve potency, selectivity, and pharmacokinetic properties, thus advancing their therapeutic potential in oncology.

Keywords

Arylpiperazine; cancer; small molecules; anti-proliferative agents

Subject

Chemistry and Materials Science, Medicinal Chemistry

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.